VanEck Pharmaceutical ETF · $1.2B$17,642
PPHPPH vsSCHDSCHDSchwab U.S. Dividend Equity ETF · $123B$16,375
$10,000 five years ago, dividends reinvested · they hold 6.9% in common
PPHMeasureSCHD
Returns · dividends reinvested
+20.4%Year to dateJan 1 → Nov 5+35.3%
+34.2%1 yearTotal return+41.6%
+19.9%3 years · per year$10,000 became $17,228 · $17,908+21.4%
+12.9%5 years · per year$10,000 became $18,329 · $16,881+11.0%
Cost and income
0.36%Expense ratio$36 · $6 a year on $10k · lower is better0.06%
1.75%Trailing 12-mo yield$175 · $291 a year on $10k2.91%
Risk · past year
−10.8%Worst dropSmaller is better−6.9%
18.7%VolatilityLower is calmer11.5%
PPHSCHD Winner of the row, in its colourEach row: the bigger of the two fills its side
1–7SCHD wins
End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns